National Cancer Center, Korea
Also known as: Bo Hyun Kim | Byung-Kiu Park | Center for Colorectal Cancer, National Cancer Center Korea | Chief, Center for Breast Cancer, National Cancer Center, Korea | Clinical Research Center for Solid Tumor, Korea | Clinical Research Center for Solid Tumors, Korea | Department of Breast and Medical Oncology, National Cancer Center Hospital | Hark Kyun Kim | Ji-youn Han | Jungsil Ro | Kim, Seoung-Hoon | Liver Cancer Center, National Cancer Center, Republic of Korea | National Cancer Center, Gyeonggi, Korea | National Cancer Center, Korea | National Cancer Center of Korea | National Cancer Center, Rep. of Korea | National Cancer Center, Republic of Korea | National Cancer Center, Seoul, Korea | National Cancer Center, South Korea | National Cencer Center, Korea | Pediatric Oncology Branch, National Cancer Center, Korea | Research Institute and Hospital, National Cancer Center Korea | Seung Duk Lee | Sokbom Kang
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2001Last known activity
Feb 28, 2026
Timeline
2000s
- Jan 1, 2000
National Cancer Center, Korea— Founded
Drugs by trial phase (92 distinct, 122 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (35 own, 0 via acquisition)
Phase 2 (55 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Acute Lung Injury
- Adenocarcinoma
- Adenocarcinoma of Lung
- Anemia
- Astrocytoma
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Cholangiocarcinoma
- Colorectal Neoplasms
- Esophageal Neoplasms
- Glioblastoma
- Head and Neck Neoplasms
- Hodgkin Disease
- Immunoblastic Lymphadenopathy
- Infections
- Lung Injury
- Lung Neoplasms
- Lymphoma
- Lymphoma, Large-Cell, Anaplastic
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Cutaneous
- Lymphoma, T-Cell, Peripheral
- Meningeal Carcinomatosis
- Neoplasm Metastasis
- Neoplasms
- Osteosarcoma
- Pancreatic Neoplasms
- Postoperative Complications
- Prostatic Neoplasms
- Rectal Neoplasms
- Recurrence
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Sarcoma
- Small Cell Lung Carcinoma
- Squamous Cell Carcinoma of Head and Neck
- Stomach Neoplasms
- Surgical Wound Infection
- Syndrome
- Thyroid Diseases
- Thyroid Neoplasms
- Triple Negative Breast Neoplasms
- Urinary Bladder Neoplasms
- Uterine Cervical Neoplasms
Recent trials (50)
- NCT07297654Sponsor investigatorPhase 2Feb 28, 2026
- NCT07297654Lead sponsorPhase 2Feb 28, 2026
- NCT07121478Lead sponsorPhase 2Sep 23, 2025
- NCT07121478Sponsor investigatorPhase 2Sep 23, 2025
- NCT07125924Sponsor investigatorN/AAug 22, 2025
- NCT07125924Lead sponsorN/AAug 22, 2025
- NCT06971965Lead sponsorN/AJun 2, 2025
- NCT06388720Lead sponsorPhase 2Apr 30, 2024
- NCT06388720OfficialPhase 2Apr 30, 2024
- NCT06388720Sponsor investigatorPhase 2Apr 30, 2024
- NCT06135896Reponsible party - principal investigatorPhase 2Dec 10, 2023
- NCT06135896Lead sponsorPhase 2Dec 10, 2023
- NCT06156527Lead sponsorPhase 2Sep 5, 2023
- NCT06156527Study chairPhase 2Sep 5, 2023
- NCT06156527Reponsible party - principal investigatorPhase 2Sep 5, 2023
Details
- Founded
- Goyang, KR Jan 1, 2000
- Last known activity
- Feb 28, 2026